Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma. | BMC Pulm Med | 2023 | 37308925 | PubTator, text mining | PubMed |
| Monitoring of Copper in Wilson Disease. | Diagnostics (Basel) | 2023 | 37296680 | PubTator, text mining | PubMed |
| Comprehensive analysis of the coding and non-coding RNA transcriptome expression profiles of hippocampus tissue in tx-J animal model of Wilson's disease. | Sci Rep | 2023 | 37286730 | PubTator, text mining | PubMed |
| Copper homeostasis dysregulation promoting cell damage and the association with liver diseases. | Chin Med J (Engl) | 2023 | 37284739 | PubTator, text mining | PubMed |
| Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37283097 | PubTator, text mining | PubMed |
| Machine learning-based identification of cuproptosis-related markers and immune infiltration in severe community-acquired pneumonia. | Clin Respir J | 2023 | 37279744 | PubTator, text mining | PubMed |
| Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease. | Front Immunol | 2023 | 37275904 | PubTator, text mining | PubMed |
| A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer. | Front Med (Lausanne) | 2023 | 37275369 | PubTator, text mining | PubMed |
| Molecular subtypes and tumor microenvironment infiltration signatures based on cuproptosis-related genes in colon cancer. | Front Oncol | 2023 | 37274263 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell-based therapies for organ fibrosis. | Front Bioeng Biotechnol | 2023 | 37274156 | PubTator, text mining | PubMed |
| Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease. | Front Immunol | 2023 | 37266442 | PubTator, text mining | PubMed |
| Potential of Copper and Copper Compounds for Anticancer Applications. | Pharmaceuticals (Basel) | 2023 | 37259382 | PubTator, text mining | PubMed |
| The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer. | BMC Bioinformatics | 2023 | 37259036 | PubTator, text mining | PubMed |
| Editorial: Genetic and proteomic biomarkers in solid tumor detection and treatment. | Front Genet | 2023 | 37252664 | PubTator, text mining | PubMed |
| Neurological-Type Wilson Disease: Epidemiology, Clinical Manifestations, Diagnosis, and Management. | Cureus | 2023 | 37252588 | PubTator, text mining | PubMed |
| A nomogram based on cuproptosis-related genes predicts 7-year relapse-free survival in patients with estrogen receptor-positive early breast cancer. | Front Oncol | 2023 | 37251943 | PubTator, text mining | PubMed |
| Treatment of liver fibrosis in hepatolenticular degeneration with traditional Chinese medicine: systematic review of meta-analysis, network pharmacology and molecular dynamics simulation. | Front Med (Lausanne) | 2023 | 37250630 | PubTator, text mining | PubMed |
| The relevance of acid sphingomyelinase as a potential target for therapeutic intervention in hepatic disorders: current scenario and anticipated trends. | Arch Toxicol | 2023 | 37248308 | PubTator, text mining | PubMed |
| Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs? | Nanomaterials (Basel) | 2023 | 37242036 | PubTator, text mining | PubMed |
| A Deep Learning Approach for Prognostic Evaluation of Lung Adenocarcinoma Based on Cuproptosis-Related Genes. | Biomedicines | 2023 | 37239150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=31